We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDB icon
301
MongoDB
MDB
$35.2B
$280K 0.03%
1,202
+265
+28% +$74.8K
ARVN icon
302
Arvinas
ARVN
$580M
$279K 0.03%
14,570
+1,367
+10% +$33.2K
NVAX icon
303
Novavax
NVAX
$1.31B
$273K 0.03%
33,965
+3,174
+10% +$30.6K
AUPH icon
304
Aurinia Pharmaceuticals
AUPH
$2.06B
$273K 0.03%
30,359
+2,857
+10% +$23.3K
DAWN
305
DELISTED
Day One Biopharmaceuticals
DAWN
$271K 0.03%
21,383
+2,180
+11% +$30.3K
QQQ icon
306
Invesco QQQ Trust
QQQ
$481B
$262K 0.02%
511
+176
+53% +$89K
VIK icon
307
Viking Holdings
VIK
$46.5B
$257K 0.02%
5,844
– –
ARDX icon
308
Ardelyx
ARDX
$1.03B
$255K 0.02%
50,222
+4,942
+11% +$27.3K
HROW icon
309
Harrow
HROW
$1.48B
$253K 0.02%
7,552
+727
+11% +$32.2K
NTLA icon
310
Intellia Therapeutics
NTLA
$1.69B
$252K 0.02%
21,596
+2,059
+11% +$32.1K
SNOW icon
311
Snowflake
SNOW
$115B
$250K 0.02%
+1,622
New +$228K
IMCR icon
312
Immunocore
IMCR
$1.77B
$248K 0.02%
8,393
+960
+13% +$30.4K
ANIP icon
313
ANI Pharmaceuticals
ANIP
$1.73B
$246K 0.02%
4,457
+412
+10% +$23.7K
RCKT icon
314
Rocket Pharmaceuticals
RCKT
$374M
$243K 0.02%
19,329
+1,824
+10% +$27.5K
SNDX icon
315
Syndax Pharmaceuticals
SNDX
$1.77B
$239K 0.02%
18,099
+1,732
+11% +$29.6K
ELVN icon
316
Enliven Therapeutics
ELVN
$4.24B
$233K 0.02%
10,360
+1,275
+14% +$33.1K
INVA icon
317
Innoviva
INVA
$1.5B
$230K 0.02%
13,274
+1,241
+10% +$23.8K
W icon
318
Wayfair
W
$14.1B
$220K 0.02%
+4,974
New +$235K
SPRY icon
319
ARS Pharmaceuticals
SPRY
$601M
$217K 0.02%
20,607
+1,962
+11% +$27.5K
AVDL
320
DELISTED
Avadel Pharmaceuticals
AVDL
$215K 0.02%
20,432
+1,916
+10% +$23.3K
VIR icon
321
Vir Biotechnology
VIR
$1.52B
$214K 0.02%
29,202
+2,922
+11% +$23K
ZYME icon
322
Zymeworks
ZYME
$1.77B
$214K 0.02%
14,605
+940
+7% +$13.1K
REPL icon
323
Replimune Group
REPL
$1.28B
$198K 0.02%
16,317
+3,177
+24% +$38.6K
COLL icon
324
Collegium Pharmaceutical
COLL
$834M
$196K 0.02%
6,838
+642
+10% +$21.2K
QURE icon
325
uniQure
QURE
$3.13B
$195K 0.02%
11,062
+969
+10% +$8.37K
11 12
13
14 15

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.